From Biotech “Mapmaker” Immunai Launches With $20M to Chart the Immune System:

IMMUNAI
IMMUNAI

(L) Luis Voloch, chief technology officer of Immunai, and Noam Solomon, (R), CEO of Immunai. Photo by Immunai.